Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data

Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data

Aim: The interaction of concomitant benzodiazepine (BZD) exposure during immune checkpoint blockade has not been comprehensively investigated to date. This research aimed to determine the influence of BZD intake on the survival outcomes of patients with metastatic non-small-cell lung cancer (NSCLC)...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabrizio Nelli, Enzo Maria Ruggeri, Antonella Virtuoso, Diana Giannarelli, Armando Raso, Federica Natoni, Gloria Pessina, Daniele Remotti, Mario Giovanni Chilelli, Carlo Signorelli, Agnese Fabbri
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2025-01-01
Series:Exploration of Targeted Anti-tumor Therapy
Subjects:
concomitant medications
non-small-cell lung cancer
immune checkpoint blockade
pembrolizumab
chemotherapy
first-line therapy
benzodiazepines
efficacy
Online Access:https://www.explorationpub.com/uploads/Article/A1002287/1002287.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items